Compare CSIS WARRANT SERIES I (CSIS-W) vs UBC Medical Indonesia Tbk. (LABS) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
CSIS WARRANT SERIES I vs UBC Medical Indonesia Tbk. — how do they compare? CSIS WARRANT SERIES I trades at Rp87 (market cap 4.6B, 1.9K 24h volume), while UBC Medical Indonesia Tbk. trades at Rp148 (market cap 576.7B, 3.14M 24h volume). The key difference: UBC Medical Indonesia Tbk. is far larger — about 125.4× CSIS WARRANT SERIES I's market cap, and UBC Medical Indonesia Tbk. is more actively traded (3.14M versus 1.9K). Which is the better fit depends on your goals.
| CSIS-W | LABS | |
|---|---|---|
Market Cap | 4.6B | 576.7B |
Volume | 1.9K | 3.14M |
Lot | 19 | 31.41K |
Turnover | 161.8K | 472.54M |
Average Price | 85.16 | 150.43 |
Value | 161.8K | 472.54M |
Indicative Equilibrium Price | — | 147 |
Indicative Equilibrium Volume | — | 311 |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About CSIS WARRANT SERIES I
PT Cahayasakti Investindo Sukses Tbk (the Company) was established based on the Deed of Notary Djurnawati Soetarmono, SH, No. 52 dated June 2, 1995. The Company belongs to a group of companies owned by PT Andalan Utama Bintara.
Read more on CSIS-W →About UBC Medical Indonesia Tbk.
PT UBC Medical Indonesia (the Company) was established under the framework of Law of the Republic of Indonesia No. 20 year 1994 concerning the Foreign Capital Investment, as amended by Law No. 25 year 2007 concerning the Capital Investment based on Notarial Deed No. 01 dated 4 June 2014 of Novita Puspitarini, S.H., Notary in Jakarta. The Company started its commercial activities in October 2014. The parent entity as well as the ultimate parent entity of the Company is PT Optel Investama Mulia.
Read more on LABS →
